![Ann R. Donoghue](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ann R. Donoghue
Conseiller Juridique Général chez VetDC, Inc.
Profil
Ann R.
Donoghue is currently a Senior Director-Regulatory Affairs at VetDC, Inc. She previously worked as an Associate Director-Product Development at Heska Corp., Director-Clinical Development & Regulatory Affairs at PR Pharmaceuticals, Inc., and Chief-Parasitology at Michigan State University.
She also worked as a Project Leader at Hoechst-Roussel Agri-Vet Co. Dr. Donoghue received her undergraduate, graduate, and doctorate degrees from Michigan State University.
Postes actifs de Ann R. Donoghue
Sociétés | Poste | Début |
---|---|---|
VetDC, Inc.
![]() VetDC, Inc. Agricultural Commodities/MillingProcess Industries VetDC, Inc. develops cancer drugs for pets. It is a cancer-focused veterinary biopharmaceutical company developing innovative, underutilized human technologies for use in companion animals. It offers VDC-1101, a novel anti-cancer pro-drug from Gilead Sciences for use in animal cancer. The company was founded by Terry J. Opgenorth in 2009 and is headquartered in Fort Collins, CO. | Conseiller Juridique Général | - |
Anciens postes connus de Ann R. Donoghue
Sociétés | Poste | Fin |
---|---|---|
Michigan State University | Corporate Officer/Principal | - |
HESKA CORPORATION | Conseiller Juridique Général | - |
PR Pharmaceuticals, Inc.
![]() PR Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology PR Pharmaceuticals, Inc. develops, manufactures and commercialization of bioactive compounds in sustained-release formulations. It offers injectable and biodegradable formulations to treat chronic diseases. It produces drug delivery technologies for human and animal health. Its products include Insular, Pulmolar, and Somalar. The company was founded in 1998 by Steve R. Howe & William R. Lance and is located in Fort Collins, CO | Conseiller Juridique Général | - |
Hoechst-Roussel Agri-Vet Co. | Corporate Officer/Principal | - |
Formation de Ann R. Donoghue
Michigan State University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 4 |
---|---|
Heska Corp.
![]() Heska Corp. Medical SpecialtiesHealth Technology Heska Corp. engages in the provision of veterinary and animal health diagnostic, and specialty products. It operates through the North America and International segments. The North America segment includes the United States, Canada, and Mexico. The International segment involves Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company was founded by Robert B. Grieve and Lynnor B. Stevenson in 1988 and is headquartered in Loveland, CO. | Health Technology |
PR Pharmaceuticals, Inc.
![]() PR Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology PR Pharmaceuticals, Inc. develops, manufactures and commercialization of bioactive compounds in sustained-release formulations. It offers injectable and biodegradable formulations to treat chronic diseases. It produces drug delivery technologies for human and animal health. Its products include Insular, Pulmolar, and Somalar. The company was founded in 1998 by Steve R. Howe & William R. Lance and is located in Fort Collins, CO | Health Technology |
VetDC, Inc.
![]() VetDC, Inc. Agricultural Commodities/MillingProcess Industries VetDC, Inc. develops cancer drugs for pets. It is a cancer-focused veterinary biopharmaceutical company developing innovative, underutilized human technologies for use in companion animals. It offers VDC-1101, a novel anti-cancer pro-drug from Gilead Sciences for use in animal cancer. The company was founded by Terry J. Opgenorth in 2009 and is headquartered in Fort Collins, CO. | Process Industries |
Hoechst-Roussel Agri-Vet Co. |